Study incorporated data from over 25,000 patients across 30 sites and compared proactive esophageal cooling to luminal temperature monitoring during RF ablation of the left atrium. CHICAGO--(BUSINESS ...
Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced that Ascension St. Vincent's has enrolled the first patient in the VITAL-EP study. The study is ...
Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
Pulse Biosciences (Nasdaq:PLSE) announced a new strategic alignment to focus on its nPulse cardiac catheter ablation system.
Visit Vektor Medical at Booth 208 to Learn More about vMap®, the VITAL-EP Registry’s AF Findings, and the Newly Released Atrial Flutter Workflow At this year’s meeting, a featured study titled "High ...
COPENHAGEN, Denmark, Jan. 29, 2026 /PRNewswire/ -- CathVision today announced significant clinical and scientific progress in Pulsed Field Ablation (PFA) with its PFAnalyzer™ software module, ...
March 17 (UPI) --Researchers suggest certain patients with atrial fibrillation, or AF, can safely stop using blood thinner medication after undergoing catheter ablation. AF is an irregular heartbeat ...
First Patient Enrolled at Ascension St. Vincent’s in Jacksonville, Florida Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced that Ascension St. Vincent ...